19th November 2026
On 1-2 June 2027, Fira Barcelona in Montjuïc will host the newest show in the international pharma calendar: CPHI Spain. The event will provide a launchpad for the Spanish pharma industry to build meaningful connections and partnerships, across the country and beyond. With all attendees sharing an active business interest in the region, the scale and setting of the show is tailored to offer all visitors the insights they need to make their mark on the country’s pharmaceutical sector.
What is CPHI Spain?
CPHI Spain is a brand new show designed to establish Spain as a key destination on the pharmaceutical map. With more 35+ years of experience in connecting the industry, CPHI will be bringing their experience with the full pharma supply chain to Barcelona, facilitating two days of connection, innovation and international pharmaceutical expertise. The show will see Montjuïc’s Fira Barcelona welcome 2500+ attendees and 130+ exhibitors over two days, helping pharma companies of all sizes find a foothold in the Spanish pharma market.
Operating on a more in-depth scale than the annual flagship CPHI Global show, the event offers the international pharma community a chance to have the in-depth discussions that drive real progress. As with all CPHI events, CPHI Spain will also provide an in-depth content programme, which will offer professional expertise in regulation and policy, as well as pricing and industry trends. There will also be range of unique networking activities and experiences, using the sights of this spectacular city as a backdrop.
In the long-term, the aim of CPHI Spain is to boost the country’s status in the pharma ecosystem, bringing tangible benefits to local and international businesses alike. For those global organisations looking to strengthen their position in the Spanish market, the event will give them access to major companies who know the local industry landscape inside and out. Meanwhile, Spanish companies can not only demonstrate the best that the country’s pharma has to offer, but position themselves as market leaders in front of a dedicated global audience.

